Study Improvement and Prevention Results
| Study Period | Study Population | (Improvement (MGPA score ≧5) | Prevention of Disease Progression (MGPA score ≧4) | Adverse Reactions | |||||
|---|---|---|---|---|---|---|---|---|---|
| 2.5 years | 3177 | 87.1% | (2230/2561) | 99.6% | (2550/2561) | 0.7% | 23/3177 | ||
| 5 years | 801 | 99.4% | (796/801) | 100.0% | (801/801) | no evaluation | |||
| 10 years | 532 | 91.5% | (487/532) | 99.1% | (527/532) | 6.8% | 36/532 | ||